Clozapine’s REMS Program Officially Over

(MedPage Today) — The FDA has officially eliminated clozapine’s risk evaluation and mitigation strategy (REMS) program, with all REMS operations stopped as of June 13.
The announcement comes several months after a joint FDA advisory committee…